Literature DB >> 26796601

Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?

Shyamal Patel1, Keyur J Mehta2, Hsiang-Chi G Kuo2, Nitin Ohri2, Rajal Patel2, Ravi Yaparpalvi2, Madhur K Garg2, Chandan Guha2, Shalom Kalnicki2.   

Abstract

PURPOSE: Within a multifraction high-dose-rate vaginal cuff brachytherapy course, we determined if individual variations in organ at risk (OAR) volume and cylinder insertion geometry (CIG) impacted dose and whether planned minus fractional (P - F) differences led to a discrepancy between planned dose and delivered dose. METHODS AND MATERIALS: We analyzed vaginal cuff brachytherapy applications from consecutive patients treated with three fractions of 5 Gy after each undergoing a planning CT and three repeat fractional CTs (fCTs). Rectal and bladder D2ccs and volumes were recorded in addition to the x (in relationship to midplane) and y (in relationship to the table) angles of CIG. Paired t-tests and multiple regression analyses were performed.
RESULTS: Twenty-seven patients were identified. In comparing the planning CT vs. mean fCT rectal volumes, bladder volumes, x angles, and y angles, only bladder volume was significantly different (planned volume higher, t = 2.433, p = 0.017). The cumulative mean planned OAR D2cc vs. delivered D2cc was only significantly different for the bladder (planned dose lower, t = -2.025, p = 0.053). Regression analysis revealed planned rectal D2cc (p < 0.0003) and a positive (posterior) y insertion angle (p = 0.015) to significantly impact delivered rectal D2cc. Additionally, P - F rectal volume (p = 0.037) was significant in determining rectal delivered dose.
CONCLUSIONS: A more posterior y angle of insertion was found to increase rectal D2cc leading us to believe that angling the vaginal cylinder anteriorly may reduce rectal dose without significantly increasing bladder dose. Although attention should be paid to OAR volume and CIG to minimize OAR dose, the clinical significance of P - F changes remains yet to be shown.
Copyright © 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cylinder insertion geometry; HDR vaginal brachytherapy; Interfraction dose variance; Organ at risk volume; Vaginal cuff brachytherapy

Mesh:

Year:  2016        PMID: 26796601     DOI: 10.1016/j.brachy.2015.11.004

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  3 in total

Review 1.  Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?

Authors:  Sebastià Sabater; Ignacio Andres; Veronica Lopez-Honrubia; Roberto Berenguer; Marimar Sevillano; Esther Jimenez-Jimenez; Angeles Rovirosa; Meritxell Arenas
Journal:  Cancer Manag Res       Date:  2017-08-09       Impact factor: 3.989

2.  Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy.

Authors:  Brien Washington; Marcus Randall; Denise Fabian; Dennis Cheek; Chi Wang; Wei Luo
Journal:  Adv Radiat Oncol       Date:  2022-07-19

3.  Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.

Authors:  Yurday Ozdemir; Yemliha Dolek; Cem Onal
Journal:  J Contemp Brachytherapy       Date:  2017-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.